Fair point Marque, but the point also to remember is that every move forward adds fundamental value to the Co & to the share fundamentals. Hopefully Santa will b better to u this year. :)Interesting times ahead.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
